EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

Primary Neurolymphomatosis: A Literature Review

Sahar Chakroun, Alice Faucher, Antoine Gueguen, Jehane Fadlallah, Emilie Corvilain, Nathalie Kubis, Pierre Lozeron iD

European Journal of Neurology · 2025-04 · 32 (4)

DOI: 10.1111/ene.70173 ↗

At a glance

Übersichtsarbeit in European Journal of Neurology, published online on 2025-04-23. Written by Sahar Chakroun and 6 co-authors. Institution: Service de Physiologie Clinique-Explorations Fonctionnelles, AP-HP, DMU DREAM, Hôpital Lariboisière, Paris, France. Major MEDLINE topics: Neurolymphomatosis. Cited 9 times so far (Crossref); 15 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Primary neurolymphomatosis (PNL) is a rare clinical entity resulting from direct lymphomatous infiltration into the peripheral nervous system. Its diagnosis is challenging as the hematological condition is unknown at the onset of neurological symptoms.

Methods

We report two of our own cases and the first extensive review of published cases of PNL to delineate its clinical features, paraclinical investigation results, progression, and treatment response more precisely. We extracted demographic data, clinical presentation, results of the investigations performed, type and number of treatments, overall survival, and progression‐free survival.

Results

We describe 301 cases of PNL in patients with a mean age of 57.9 years, 61% of whom were men. The most common clinical presentation was an often painless asymmetric neuropathy. Other presentations included multifocal neuropathy preferentially affecting the sciatic and peroneal nerves, radiculopathy, brachial plexus lesions, cauda equina syndrome, and cranial nerve palsy. Systemic signs and deterioration of clinical status were uncommon. Diagnosis was established after a median of 8 months, based on histological results (76%) or a cluster of elements in cases of positive PET findings. A B‐cell lymphoma was diagnosed in 73% of cases. Systemic chemotherapy (90%) and rituximab (60%) were the most common treatments, with a response rate of 45%. Relapse occurred in 24% of patients, and 55% ultimately died from PNL. Overall survival was 28 months. Type of treatment was not associated with survival.

Conclusions

This literature review provides an overview of the available data concerning PNL presentation and progression.

Subjects

MeSH terms (MEDLINE)

NeurolymphomatosisAdultAgedFemaleHumansMaleMiddle Aged

Author keywords

MRIPETlymphomaneuropathysurvival

Authors and institutions

  • Service de Physiologie Clinique-Explorations Fonctionnelles, AP-HP, DMU DREAM, Hôpital Lariboisière, Paris, France.
  • Service de Neurologie, Hôpital Fondation Adolphe de Rothschild, Paris, France.
  • Service D'immuno Pathologie Clinique, Hôpital Saint Louis, APHP, Paris, France.
  • Université Paris Cité, INSERM UMR-S1144, Optimisation Thérapeutique en Neuropsychopharmacologie, Faculté de Pharmacie de Paris, Paris, France.
  • Centre de Compétence Neuropathies Rares et Amyloïdes Ile-de France Caraïbes (CERAMIC), FILNEMUS, AP-HP, DMU DREAM, Hôpital Lariboisière, Paris, France.

ORCID profiles: Pierre Lozeron

Cite

APA

Chakroun, S., Faucher, A., Gueguen, A., Fadlallah, J., Corvilain, E., Kubis, N., & Lozeron, P. (2025). Primary Neurolymphomatosis: A Literature Review. European Journal of Neurology, 32(4). https://doi.org/10.1111/ene.70173

Vancouver

Chakroun S, Faucher A, Gueguen A, Fadlallah J, Corvilain E, Kubis N, et al. Primary Neurolymphomatosis: A Literature Review. European Journal of Neurology. 2025;32(4). doi:10.1111/ene.70173

BibTeX
@article{Chakroun2025,
  author = {Chakroun, Sahar and Faucher, Alice and Gueguen, Antoine and Fadlallah, Jehane and Corvilain, Emilie and Kubis, Nathalie and Lozeron, Pierre},
  title = {Primary Neurolymphomatosis: A Literature Review},
  journal = {European Journal of Neurology},
  year = {2025},
  volume = {32},
  number = {4},
  doi = {10.1111/ene.70173}
}
Start for free →